These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 10955648)

  • 1. Broadband time-domain reflectometry measurement of attenuation and phase velocity in highly attenuating suspensions with application to the ultrasound contrast medium Albunex.
    Hughes MS; Klibanov AL; Marsh JN; Miller JG; Brandenburger GH
    J Acoust Soc Am; 2000 Aug; 108(2):813-20. PubMed ID: 10955648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Broadband measurements of phase velocity in Albunex suspensions.
    Mobley J; Marsh JN; Hall CS; Hughes MS; Brandenburger GH; Miller JG
    J Acoust Soc Am; 1998 Apr; 103(4):2145-53. PubMed ID: 9566335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transmission measurements of Albunex attenuation and phase velocity at concentrations approaching in vivo doses.
    Adams M; Marsh JN; Hall CS; Mobley J; Hughes MS; Miller JG; Brandenburger GH
    Acad Radiol; 1996 Aug; 3 Suppl 2():S182-4. PubMed ID: 8796556
    [No Abstract]   [Full Text] [Related]  

  • 4. Experimental study of stability of a contrast agent in an ultrasound field.
    Wu J; Tong J
    Ultrasound Med Biol; 1998 Feb; 24(2):257-65. PubMed ID: 9550184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Broadband measurement of the scattering-to-attenuation ratio for Albunex at 37 degrees C.
    Marsh JN; Hughes MS; Brandenburger GH; Miller JG
    Ultrasound Med Biol; 1999 Oct; 25(8):1321-4. PubMed ID: 10576274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasound scattering properties of Albunex microspheres.
    de Jong N; Hoff L
    Ultrasonics; 1993; 31(3):175-81. PubMed ID: 8484195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A broad band spectroscopy method for ultrasound wave velocity and attenuation measurement in dispersive media.
    Peters F; Petit L
    Ultrasonics; 2003 Jul; 41(5):357-63. PubMed ID: 12788217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acoustic modeling of shell-encapsulated gas bubbles.
    Frinking PJ; de Jong N
    Ultrasound Med Biol; 1998 May; 24(4):523-33. PubMed ID: 9651962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temperature rise generated by ultrasound in the presence of contrast agent.
    Wu J
    Ultrasound Med Biol; 1998 Feb; 24(2):267-74. PubMed ID: 9550185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the application of ultrasonic contrast agents for blood flowmetry and assessment of cardiac perfusion.
    Bleeker H; Shung K; Barnhart J
    J Ultrasound Med; 1990 Aug; 9(8):461-71. PubMed ID: 2204718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theoretical and experimental investigation of the behaviour of ultrasound contrast agent particles in whole blood.
    Stride E; Saffari N
    Ultrasound Med Biol; 2004 Nov; 30(11):1495-509. PubMed ID: 15588960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of contrast intensity during systole in the left ventricular cavity with the use of the contrast agent Albunex. An analysis of its correlation with pressure and velocity.
    Tiukinhoy S; Bhoopalam S; Winkelmann JW; Ammar K; Mangulabnan L; Reddy G; Fernandez A; Block R; Malhotra V; Feinstein S
    Invest Radiol; 1996 Jul; 31(7):415-22. PubMed ID: 8818781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of static pressure on acoustic transmittance of Albunex microbubble suspensions.
    Brayman AA; Azadniv M; Miller MW; Meltzer RS
    J Acoust Soc Am; 1996 Apr; 99(4 Pt 1):2403-8. PubMed ID: 8730086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental validation of a time domain simulation of high frequency ultrasonic propagation in a suspension of rigid particles.
    Galaz B; Haïat G; Berti R; Taulier N; Amman JJ; Urbach W
    J Acoust Soc Am; 2010 Jan; 127(1):148-54. PubMed ID: 20058958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second harmonic characteristics of the ultrasound contrast agents albunex and FSO69.
    Krishna PD; Newhouse VL
    Ultrasound Med Biol; 1997; 23(3):453-9. PubMed ID: 9160913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of mitral flow assessment by echo-contrast ultrasound, part I: determination of the properties of echo-contrast agents.
    Herman B; Einav S; Vered Z
    Ultrasound Med Biol; 2000 Jun; 26(5):787-95. PubMed ID: 10942826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemolysis of 40% hematocrit, Albunex-supplemented human erythrocytes by pulsed ultrasound: frequency, acoustic pressure and pulse length dependence.
    Brayman AA; Strickler PL; Luan H; Barned SL; Raeman CH; Cox C; Miller MW
    Ultrasound Med Biol; 1997; 23(8):1237-50. PubMed ID: 9372572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of the attenuation coefficient for monodisperse populations of ultrasound contrast agents.
    Gong Y; Cabodi M; Porter TM
    Annu Int Conf IEEE Eng Med Biol Soc; 2009; 2009():1964-6. PubMed ID: 19964023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Albunex--a new ultrasound contrast agent. Effects on hemodynamics, contrast, and biodistribution in different species.
    Walday P; Ostensen J; Tolleshaug H; Holtz E
    Invest Radiol; 1994 Jun; 29 Suppl 2():S142-4. PubMed ID: 7928211
    [No Abstract]   [Full Text] [Related]  

  • 20. Ultrasonically induced hemolysis at high cell and gas body concentrations in a thin-disc exposure chamber.
    Miller DL; Gies RA; Chrisler WB
    Ultrasound Med Biol; 1997; 23(4):625-33. PubMed ID: 9232772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.